Aclid, Inc.
New York, NY
- UEI
- MC9NKY6NRRQ5
- CAGE
- 9BWZ1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 920 Broadway floor 15, New York, NY 10010, USA
- Website
- aclid.bio
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sibr phase i - aclid nucleotide sequencing research and development study | Defense Threat Reduction Agency | $167,338 | |
| A biosecurity platform for the identification of natural and engineered biological threats | Air Force Research Laboratory | $74,933 |
Quick answers
What is Aclid, Inc.'s UEI?
Aclid, Inc.'s Unique Entity ID (UEI) in SAM.gov is MC9NKY6NRRQ5.
What is Aclid, Inc.'s CAGE code?
Aclid, Inc.'s CAGE code is 9BWZ1.
What is Aclid, Inc.'s primary NAICS code?
Aclid, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Aclid, Inc. located?
Aclid, Inc.'s physical address in SAM.gov is 920 Broadway floor 15, New York, NY 10010, USA.
Is Aclid, Inc. registered in SAM.gov?
Yes. Aclid, Inc.'s SAM.gov registration is active through December 29, 2026.
What is Aclid, Inc.'s most recent federal award?
Aclid, Inc.'s most recent federal contract award is Sibr phase i - aclid nucleotide sequencing research and development study (HDTRA124P0047), from Defense Threat Reduction Agency, on October 21, 2024.
On GovTribe
See Aclid, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors